Joint Formulary & PAD

Ethinylestradiol with desogestrel - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Preferred

Preferred brands: Gedarel 20/150, Bimezza

 

Status 2

Non Formulary
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

Mercilon

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ethinylestradiol with desogestrel
Indication :
Contraception
Group Name :
Keywords :
Brand Names Include :
Gedarel 20/150, Bimezza, Mercilon,
Important Information :

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Ethinylestradiol with desogestrel is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Contraception.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.